Jayne Crisman

Jayne Crisman is a Senior Analyst covering the Communication Services & Technology sector. Prior to joining Tech Insider in 2000, she worked at J.C. Bradford & Co. and Hoak Breedlove Wesneski & Co. covering wireless communications, and at Fidelity Investments before that. She is a five-time winner of the Wall Street Journal’s “Best on the Street” analysts survey, including ranking No. 1 in 2012 in the Telecommunications Equipment category.

Mid Cap Active Runners: Rite Aid Corporation (NYSE:RAD), Safeway Inc. (NYSE:SWY), Kinross Gold (NYSE:KGC), J.C. Penney Company (NYSE:JCP)

Two families were displaced and three stores were destroyed in a five-alarm fire in Jersey City early yesterday morning. Two firefighters suffered smoke inhalation and were sent to the Jersey City Medical Center, where they were treated and released, Jersey City Assistant Public Safety Director Jerry Cala said. The second floor of a Rite Aid…

Read More

Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was…

Read More

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average…

Read More

Biotech Active Movers: Ariad Pharmaceuticals (NASDAQ:ARIA), Insmed Incorporated (NASDAQ:INSM), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals (NYSEMKT:INO)

Earlier this week, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it has initiated a phase II pivotal study that will evaluate the safety and efficacy of AP26113 in locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who had previously been treated with Pfizer’s (PFE – Analyst Report) Xalkori (crizotinib). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)…

Read More

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. Pfizer Inc. (NYSE:PFE) stock performance was 1.05% in last session and finished the day at $31.82. Traded volume was 21.09million shares in the…

Read More

Basic Material Active Stocks: Petroleo Brasileiro Petrobras (NYSE:PBR), Alcoa Inc (NYSE:AA), Vale (NYSE:VALE), Kinross Gold Corporation (USA) (NYSE:KGC)

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), or Petrobras, is the state-controlled oil and gas giant. Petrobras has burned many investors on the other side of the Americas, largely because its capital structure is set up to take care of common shareholders further down the road – the Brazilian taxpayers (or consumers), its employees and workforce,…

Read More